Gene delivery improved memory in mice modeling Alzheimer’s
Gene delivery in an Alzheimer’s mouse model improved memory at two and six months, while partly normalizing disease-related changes in brain fats.
Our read
Interventions- Studied:
- Experiments in female mice modeling Alzheimer's disease, against AD mice receiving null vector
- What changed:
- PLA2G4E gene delivery improved memory in Alzheimer's-model mice compared with null-vector controls
- The catch:
- Male mice were diverted to lipidomics, leaving only females for the later memory assessment
Editor of record: Boris Djordjevic · AgingResearch.News
APPNL-G-F mice, a model of Alzheimer’s disease, received a gene-carrying virus in an animal experiment to raise brain levels of PLA2G4E, a protein involved in fat metabolism. Mice received an injection at 4 to 5 months of age; controls received a virus without the added gene.
Memory improved in males after two months; females showed no significant change then. At six months, memory deficits were rescued in females, the only sex tested then. Gene delivery also reduced levels of a chemically modified form of tau, a brain protein. Analysis of brain fats showed partial normalization of disease-related changes. In separate experiments, wild-type mice aged 18 to 20 months also showed better memory and increased whole-brain glucose metabolism two months after injection.
Why it matters
Disrupted brain fat metabolism is implicated in Alzheimer’s disease. The authors identify PLA2G4E as a promising target for efforts to restore cognition.
Caveats
The experiments measured memory through behavioral tests in mice, not benefits in people with Alzheimer’s disease. Changes in brain fats accompanied memory recovery, but whether they accounted for that recovery remained the authors’ proposed explanation.
The paper
Reprogramming lipid metabolism for cognitive restoration in Alzheimer's via PLA2G4E
Navarre Institute of Health Research
Alzheimer's & Dementia, Jul 5, 2026, Open access
Comments
Be the first to comment.